Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 9, 2012, Pages 1051-1052

  Cunnington, Anne Louise ^a   White, Lesley ^b   Hood, Kay ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

Author keywords

Dopamine agonist (DA); Dopamine agonist withdrawal syndrome (DAWS); Impulse control disorders (ICD); Parkinson's disease; Risk factors

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

AGED; ANKLE EDEMA; APATHY; CONFUSION; DOPAMINE AGONIST WITHDRAWAL SYNDROME; DROWSINESS; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSKINESIA; FEMALE; HALLUCINATION; HUMAN; IMPULSE CONTROL DISORDER; LETTER; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SOMNOLENCE; WITHDRAWAL SYNDROME;

AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84869101234     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.05.012     Document Type: Letter

References (5)

1. ® prescribing information http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser%3FdocBase%20%3Drenetnt%26folderPath%3D/Prescribing+Information/PIs/Mirapex/Mirapex.pdf.
2. ® prescribing information http://us.gsk.com/products/assets/us_requip.pdf.
3. Rabinak C.A., Nirenberg M.J. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010, 67(1):58-63.
4. Lindahl A.J., MacMahon D.G. Managing dopamine agonist withdrawal syndrome in Parkinson's disease. Prog Neurol Psychiatr 2011, 15(4):4-5.
5. Thobois S., Broussolle E., Kombo M.A., Pollak P., Krack P. Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery. Brain 2010, 133(11):e156.